The Power of GLP-1 Agonists with Dr. Ben Goins
Recorded live at the 2025 Atlanta Cardiovascular Symposium, we explore groundbreaking advancements at the intersection of cardiology and metabolic health. Join Dr. Ben Goins from Heart and Vascular Care as we take a deep dive into the emerging role of GLP-1 Agonists—a class of medications transforming the way we manage cardiovascular risk, obesity, diabetes, and more. Discover how these therapies are not only helping patients lose weight but also reducing the risk of major adverse cardiovascular events and improving outcomes in complex, high-risk populations. Whether you're a provider navigating the evolving landscape of cardiometabolic care or a patient advocate seeking to stay informed, this episode offers expert insights into one of today’s most promising therapeutic tools.

Are We Using GLP-1 Medications All Wrong? with Dr. Ben Bikman

Cardiovascular Benefits of GLP-1 RAs

Understanding POTS & Autonomic Dysfunction with Dr. Howard Snapper

2026 GRAPPA Virtual Congress Highlights EULAR

Mastering GLP1 Agonists: What is microdosing? Dosing schedule, benefits, and more

Eli Lilly CEO: How GLP-1s Will Reshape America

Can You Guess Our Top 5? | Smosh Mouth 149

Baim Grand Rounds Katherine Tuttle 15Jun2026

150: Why Tirzepatide Works Better Than GLP-1 Alone

2026 Atlanta Cardiovascular Symposium | Coronary Plaque Analysis

I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.

The Ultimate GLP-1 Guide: Weight Loss, Side Effects & Sarcopenia Risk

Hit a Weight Loss Plateau on GLP-1s? Doctor Explains Your Options

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

Hepatology and Liver Transplantation | Approach to Alcohol Use in the Context of Transplantation

Weight loss injections offer hope: What else can the active ingredient GLP-1 do? | Puls | SRF Wissen

Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data

7 Ozempic Blocking “Health” Foods Stalling Your Weight loss | Dr. Stirrett

What’s Next in Type 1 Diabetes? Screening, Research Breakthroughs, and the Future of Care

